Trial
NCT03423264
PROGRESS Trial - Prophylactic Gabapentin for Relief of Symptoms and Improved Swallowing
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Chicago
Collaborators
—
Condition
Oropharyngeal Cancer
Intervention
Gabapentin
Why stopped
unable to accrue
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-07-31